心血管疾病的多基因风险评分:美国心脏协会的科学声明
Circulation
|July 21, 2022
概括
多基因风险评分提供了一种预测心血管疾病风险的新方法. 这篇评论涵盖了它们的科学,临床用途以及冠状动脉疾病和2型糖尿病等疾病的未来挑战.
科学领域:
- 心血管遗传学和精确医学.
背景情况:
- 心血管疾病仍然是导致残疾和死亡的主要原因.
- 目前的风险预测方法不准确,需要改进策略.
- 遗传因素对心血管健康和疾病起着重要作用.
研究的目的:
- 审查心血管疾病的多基因风险评分 (PRS) 的当代科学.
- 讨论与PRS实施相关的临床考虑和未来挑战.
- 为医疗保健专业人员,研究人员,政策制定者和患者提供PRS的临时指导.
主要方法:
- 对多基因风险评分的当代科学文献的审查.
- 专注于五种心脏代谢疾病:冠状动脉疾病,高胆固醇血症,2型糖尿病,心房动和静脉血栓塞性疾病.
- 考虑PRS对药物治疗的反应
主要成果:
- 基因技术的进步促进了基于人口的基因分析.
- 全基因组关联研究和PRS发展正在阐明因果机制.
- PRS越来越多地被纳入研究和直接面向消费者的测试中.
结论:
- 多基因风险得分在临床接触中变得越来越普遍.
- 了解PRS的科学和临床效用对于有效实施至关重要.
- 在预防和治疗心血管疾病方面需要指导.
相关概念视频
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
976
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
976
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891


